Lixiang Zhai

1.5k total citations
27 papers, 625 citations indexed

About

Lixiang Zhai is a scholar working on Molecular Biology, Pharmacology and Complementary and alternative medicine. According to data from OpenAlex, Lixiang Zhai has authored 27 papers receiving a total of 625 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Pharmacology and 5 papers in Complementary and alternative medicine. Recurrent topics in Lixiang Zhai's work include Gastrointestinal motility and disorders (5 papers), Pharmacological Effects of Natural Compounds (5 papers) and Diet and metabolism studies (4 papers). Lixiang Zhai is often cited by papers focused on Gastrointestinal motility and disorders (5 papers), Pharmacological Effects of Natural Compounds (5 papers) and Diet and metabolism studies (4 papers). Lixiang Zhai collaborates with scholars based in China, Hong Kong and United Kingdom. Lixiang Zhai's co-authors include Zhaoxiang Bian, Haitao Xiao, Chengyuan Lin, Michael Heinrich, Jiao Peng, Anthony Booker, Bo Wen, Ling Zhao, Tao Huang and Hoi Leong Xavier Wong and has published in prestigious journals such as Nature Communications, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Lixiang Zhai

24 papers receiving 619 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lixiang Zhai China 14 345 141 141 91 65 27 625
Baoshun Zhang China 17 385 1.1× 106 0.8× 173 1.2× 52 0.6× 67 1.0× 39 809
Ki‐Kwang Oh South Korea 16 328 1.0× 84 0.6× 162 1.1× 70 0.8× 53 0.8× 52 728
Iva Potočnjak Croatia 13 270 0.8× 106 0.8× 173 1.2× 57 0.6× 66 1.0× 16 773
Opeyemi Iwaloye Nigeria 16 297 0.9× 122 0.9× 130 0.9× 179 2.0× 48 0.7× 53 867
Rebamang A. Mosa South Africa 13 251 0.7× 112 0.8× 82 0.6× 99 1.1× 48 0.7× 40 536
Iqra Sarfraz Pakistan 14 398 1.2× 130 0.9× 91 0.6× 38 0.4× 77 1.2× 23 816
Aristatile Balakrishnan Saudi Arabia 14 164 0.5× 108 0.8× 105 0.7× 98 1.1× 57 0.9× 24 555
Prosenjit Saha India 20 337 1.0× 139 1.0× 76 0.5× 61 0.7× 100 1.5× 46 789
Xilan Tang China 13 260 0.8× 91 0.6× 96 0.7× 111 1.2× 115 1.8× 35 719

Countries citing papers authored by Lixiang Zhai

Since Specialization
Citations

This map shows the geographic impact of Lixiang Zhai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lixiang Zhai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lixiang Zhai more than expected).

Fields of papers citing papers by Lixiang Zhai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lixiang Zhai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lixiang Zhai. The network helps show where Lixiang Zhai may publish in the future.

Co-authorship network of co-authors of Lixiang Zhai

This figure shows the co-authorship network connecting the top 25 collaborators of Lixiang Zhai. A scholar is included among the top collaborators of Lixiang Zhai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lixiang Zhai. Lixiang Zhai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Yaqi, Ziwan Ning, Qin Liu, et al.. (2025). Gut microbe-derived aromatic trace amines mediate individual variability in response to herbal medicine CDD-2101 for functional constipation. Pharmacological Research. 217. 107810–107810. 1 indexed citations
2.
Zhai, Lixiang, Min Zhuang, Chengyuan Lin, et al.. (2025). SARS‐CoV‐2 Spike Protein as a Target of the COVID‐19 Vaccine Disrupts Insulin Signaling in Type 2 Diabetes. MedComm. 6(11). e70469–e70469.
3.
4.
Liu, Qin, Ping Zheng, Xuanting Jiang, et al.. (2025). Multi-kingdom microbiota analysis reveals bacteria-viral interplay in IBS with depression and anxiety. npj Biofilms and Microbiomes. 11(1). 129–129. 3 indexed citations
5.
Asthana, Pallavi, Lixiang Zhai, Yijing Zhang, et al.. (2024). Artesunate treats obesity in male mice and non-human primates through GDF15/GFRAL signalling axis. Nature Communications. 15(1). 1034–1034. 16 indexed citations
6.
Zhai, Lixiang, Wei Yang, Chun‐Hua Huang, et al.. (2023). Altered gut microbiota–host bile acid metabolism in IBS-D patients with liver depression and spleen deficiency pattern. Chinese Medicine. 18(1). 87–87. 5 indexed citations
7.
Yang, Wei, Zhenxing Ren, Lifeng Li, et al.. (2023). Aqueous cinnamon extract ameliorates bowel dysfunction and enteric 5-HT synthesis in IBS rats. Frontiers in Pharmacology. 13. 1010484–1010484. 10 indexed citations
8.
Zhu, Guanglin, et al.. (2023). Network Pharmacology Study of Bioactive Components and Molecular Mechanisms of the Glycoside Fraction from Picrorhiza scrophulariiflora Against Experimental Colitis. Drug Design Development and Therapy. Volume 17. 1531–1546. 4 indexed citations
9.
Peng, Jiao, Lixiang Zhai, Yan Chen, et al.. (2022). P2Y1R Ligation Suppresses Th17 Cell Differentiation and Alleviates Colonic Inflammation in an AMPK-Dependent Manner. Frontiers in Immunology. 13. 820524–820524. 7 indexed citations
10.
Zhai, Lixiang, Jiao Peng, Min Zhuang, et al.. (2022). Therapeutic effects and mechanisms of Zhen-Wu-Bu-Qi Decoction on dextran sulfate sodium-induced chronic colitis in mice assessed by multi-omics approaches. Phytomedicine. 99. 154001–154001. 19 indexed citations
11.
Zhai, Lixiang, et al.. (2021). Phytochemicals as regulators of Th17/Treg balance in inflammatory bowel diseases. Biomedicine & Pharmacotherapy. 141. 111931–111931. 63 indexed citations
12.
Zhai, Lixiang, Tao Huang, Haitao Xiao, et al.. (2020). Berberine Suppresses Colonic Inflammation in Dextran Sulfate Sodium–Induced Murine Colitis Through Inhibition of Cytosolic Phospholipase A2 Activity. Frontiers in Pharmacology. 11. 576496–576496. 29 indexed citations
13.
Huang, Haifeng, Xianqian Li, Lixiang Zhai, et al.. (2020). Anti-inflammatory properties of uvaol on DSS-induced colitis and LPS-stimulated macrophages. Chinese Medicine. 15(1). 43–43. 41 indexed citations
14.
Ning, Ziwan, Lixiang Zhai, Tao Huang, et al.. (2019). Identification of α-glucosidase inhibitors fromcyclocarya paliurustea leaves using UF-UPLC-Q/TOF-MS/MS and molecular docking. Food & Function. 10(4). 1893–1902. 70 indexed citations
15.
Zhai, Lixiang, Jiao Peng, Ling Zhao, et al.. (2019). Simultaneous UPLC–TQ-MS/MS determination of six active components in rat plasma: application in the pharmacokinetic study of Cyclocarya paliurus leaves. Chinese Medicine. 14(1). 28–28. 17 indexed citations
16.
Wang, Li, Jing Hao, Lixiang Zhai, Yang Zhang, & Wen‐Kui Dong. (2017). Synthesis, Crystal Structure, Luminescence, Electrochemical and Antimicrobial Properties of Bis(salamo)-Based Co(II) Complex. Crystals. 7(9). 277–277. 31 indexed citations
17.
Booker, Anthony, et al.. (2016). From Traditional Resource to Global Commodities:—A Comparison of Rhodiola Species Using NMR Spectroscopy—Metabolomics and HPTLC. Frontiers in Pharmacology. 7. 254–254. 51 indexed citations
18.
Zhai, Lixiang, et al.. (2015). Ex Vivo and In Situ Evaluation of ‘Dispelling-Wind’ Chinese Medicine Herb-Drugs on Intestinal Absorption of Chlorogenic Acid. Phytotherapy Research. 29(12). 1974–1981. 16 indexed citations
19.
Booker, Anthony, Banaz Jalil, Eike Reich, et al.. (2015). The authenticity and quality of Rhodiola rosea products. Phytomedicine. 23(7). 754–762. 71 indexed citations
20.
Zhai, Lixiang, et al.. (2007). [Influence of compatibility on content of berberine in Maxingganshi decoction].. PubMed. 30(5). 602–5. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Baoshun Zhang Breakdown of academic impact, for papers by Ki‐Kwang Oh Breakdown of academic impact, for papers by Iva Potočnjak Breakdown of academic impact, for papers by Opeyemi Iwaloye Breakdown of academic impact, for papers by Rebamang A. Mosa Breakdown of academic impact, for papers by Iqra Sarfraz Breakdown of academic impact, for papers by Aristatile Balakrishnan Breakdown of academic impact, for papers by Prosenjit Saha Breakdown of academic impact, for papers by Xilan Tang
Rankless by CCL
2026